4 completed, 2 terminated, 2 unknown, 1 not yet recruiting. 2 Not applicable, 2 Phase 2, 2 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Parapsoriasis: new trials by email Literature Review of Parapsoriasis trials Research Report on Parapsoriasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interleukin-4 in Pityriasis Lichenoides Chronica skin biopsy and serum sample - Pityriasis Lichenoides | Not applicable | Not yet recruiting | Cairo University | 50 | 2025-04-01 | 2025-03-21 |
| Dermoscopic Findings of Small Plaque Parapsoriasis and Patch Stage Mycosis Fungoides and Histopathological Correlation videodermoscopy, lesional capillaroscopy - Mycosis Fungoides of Skin | Completed | Istanbul Training and Research Hospital | 60 | 2022-02-14 | 2022-06-30 | |
| Pityriasis Lichenoides : Anatomo-clinical Aspects and Follow-up Pityriasis Lichenoides | Unknown | Assistance Publique - Hôpitaux de Paris | 52 | 2019-05-01 | 2019-04-19 | |
| Pityriasis Lichenoides Chronica, Role of Streptococcal Infection and Azithromycin Azithromycin, nbUVB - Pityriasis Lichenoides | Not applicable | Unknown | Cairo University | 30 | 2019-02-01 | 2019-02-05 |
| Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis CC-90005, Placebo - Parapsoriasis, Healthy Volunteers | Phase 1 | Terminated | Celgene | 24 | 2015-07-17 | 2019-11-18 |
| A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis. Apremilast, Placebo, Placebo-Apremilast - Parapsoriasis | Phase 4 | Completed | Amgen | 221 | 2015-04-20 | 2023-06-05 |
| Natural Gels for Treatment of Plaque Psoriasis natural gels, Placebo - Parapsoriasis | Phase 2 / Phase 3 | Completed | Secret of Youth | 45 | 2015-01-01 | 2018-07-23 |
| A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis Infliximab - Psoriasis, Parapsoriasis | Phase 3 | Completed | Centocor, Inc. | 683 | 2003-01-01 | 2011-05-17 |
| Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis Bexarotene 1% gel - Parapsoriasis | Phase 2 | Terminated | Fox Chase Cancer Center | 8 | 2001-04-01 | 2013-04-16 |
Pityriasis Lichenoides (3) · Lymphoma, T-Cell, Cutaneous (2) · Mycosis Fungoides (2) · Lymphoma, Follicular (1) · Psoriasis (1)
Skin Diseases (9) · Skin Diseases, Papulosquamous (9) · Skin and Connective Tissue Diseases (9) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoma (4) · Lymphoma, Non-Hodgkin (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Lichenoid Eruptions (3) · Lymphoma, T-Cell (3)
Azithromycin (1) · Bexarotene (1) · Gels (1) · Infliximab (1) · apremilast (1)
Cairo University (2) · Amgen (1) · Assistance Publique - Hôpitaux de Paris (1) · Celgene (1) · Centocor, Inc. (1) · Fox Chase Cancer Center (1) · Istanbul Training and Research Hospital (1) · Secret of Youth (1)
United States (3) · Egypt (1) · Israel (1) · Turkey (Türkiye) (1)
Ayse Esra Koku Aksu, MD (1) · Felix Pavlotzky, MD (1) · Maria Palmisano, MD (1) · Stuart R. Lessin, M.D. (1)
PMID 17097378, PMID 29462231, PMID 36129521, PMID 37316690, PMID 42825996